Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Buchwald H, Varco RL. Editors, metabolic surgery. New York: Grune and Stratton; 1978.

    Google Scholar 

  2. 2.

    Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med. 1990;323(14):946–55.

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Kremen AJ, Linner LH, Nelson CH. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg. 1954;140(3):439–48.

    CAS  PubMed Central  Article  PubMed  Google Scholar 

  4. 4.

    Buchwald H. The evolution of metabolic/bariatric surgery. Obes Surg. 2014;24(8):1126–35.

    PubMed  Article  Google Scholar 

  5. 5.

    Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care. 2009;32(12):2297–9.

    PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    NIH conference. Gastrointestinal surgery for severe obesity. consensus development conference panel. Ann Intern Med. 1991;115(12):956–61.

    Article  Google Scholar 

  7. 7.

    Sjöström L, Lindroos AK, Peltonen M, et al. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.

  8. 8.

    Sjöström L, Gummesson A, Sjöström CD, et al. Swedish Obese Subjects Study. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10(7):653–62.

    PubMed  Article  Google Scholar 

  9. 9.

    Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.

    PubMed  Article  Google Scholar 

  10. 10.

    Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Dixon JB, Zimmet P, Alberti KG, et al. International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28(6):628–42.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  12. 12.

    Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.

    PubMed  Article  Google Scholar 

  13. 13.

    Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA. 2013;309(21):2240–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  14. 14.

    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery. a systemic review and meta-analysis. JAMA. 2004;292(14):1724–37.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Christou NV, Lieberman M, Sampalis F, et al. Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis. 2008;4(6):691–5.

    PubMed  Article  Google Scholar 

  16. 16.

    Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416–23.

    PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Busetto L, Mirabelli D, Petroni ML, et al. Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis. 2007;3(5):496–502.

    PubMed  Article  Google Scholar 

  18. 18.

    Aguiar IC, Freitas Jr WR, Santos IR, et al. Obstructive sleep apnea and pulmonary function in patients with severe obesity before and after bariatric surgery: a randomized clinical trial. Multidiscip Respir Med. 2014;9(1):43.

    PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122(6):535–42.

    PubMed  Article  Google Scholar 

  20. 20.

    Poirier P, Cornier MA, Mazzone T, et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123(15):1683–701.

    PubMed  Article  Google Scholar 

  21. 21.

    Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56. e5.

    PubMed  Article  Google Scholar 

  22. 22.

    Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.

    PubMed  Article  Google Scholar 

  23. 23.

    Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1–452.

  24. 24.

    Wang J, Thornton JC, Russell M, et al. Asians have lower body mass index (BMI) but higher percent body fat than do Whites: comparisons of anthropometric measurements. Am J Clin Nutr. 1994;60(1):23–8.

    CAS  PubMed  Google Scholar 

  25. 25.

    Yajnik CS. Obesity epidemic in India: intrauterine origins? Proc Nutr Soc. 2004;63(3):387–96.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Ko GT, Tang JS. Waist circumference and BMI cut-off based on 10-year cardiovascular risk: evidence for “central pre-obesity”. Obesity (Silver Spring). 2007;15(11):2832–9.

    Article  Google Scholar 

  27. 27.

    Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14:353–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335–42.

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Summary of revisions for the 2009 clinical practice recommendations. Diabetes Care. 2009;32 Suppl 1:S3–5.

  30. 30.

    Dixon JB, Zimmet P, Alberti KG. Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Surg Obes Relat Dis. 2011;7(4):433–47.

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Lakdawala M, Bhasker A. Asian Consensus Meeting on Metabolic Surgery (ACMOMS). Report: Asian consensus meeting on metabolic surgery. Recommendations for the use of bariatric and gastrointestinal metabolic surgery for treatment of obesity and type II diabetes mellitus in the Asian population: August 9th and 10th, 2008, Trivandrum, India. Obes Surg. 2010;20(7):929–36.

    PubMed  Article  Google Scholar 

  32. 32.

    Müller MJ, Lagerpusch M, Enderle J, et al. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev. 2012;13 Suppl 2:6–13.

    PubMed  Article  Google Scholar 

  33. 33.

    Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology. 2003;144(12):5159–65.

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Kragelund C, Omland T. A farewell to body-mass index? Lancet. 2005;366(9497):1589–91.

    PubMed  Article  Google Scholar 

  35. 35.

    Okorodudu DO, Jumean MF, Montori VM, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond). 2010;34(5):791–9.

    CAS  Article  Google Scholar 

  36. 36.

    Expert Consultation WHO. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63.

    Article  Google Scholar 

  37. 37.

    Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009;33(3):289–95.

    CAS  Article  Google Scholar 

  38. 38.

    Padwal RS, Pajewski NM, Allison DB, et al. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011;183(14):E1059–66.

    PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Kuk JL, Ardern CI, Church TS, et al. Edmonton obesity staging system: association with weight history and mortality risk. Appl Physiol Nutr Metab. 2011;36(4):570–6.

    PubMed  Article  Google Scholar 

  40. 40.

    Gill RS, Karmali S, Sharma AM. The potential role of the Edmonton obesity staging system in determining indications for bariatric surgery. Obes Surg. 2011;21(12):1947–9.

    PubMed  Article  Google Scholar 

  41. 41.

    Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–54.

    Article  Google Scholar 

  42. 42.

    De Maria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007;3(2):134–40.

    Article  Google Scholar 

  43. 43.

    Blackstone RP, Cortes MC. Metabolic acuity score: effect on major complications after bariatric surgery. Surg Obes Relat Dis. 2010;6(3):267–73.

    PubMed  Article  Google Scholar 

  44. 44.

    Guo X, Liu X, Wang M, et al. The effects of bariatric procedures versus medical therapy for obese patients with type 2 diabetes: meta-analysis of randomized controlled trials. Biomed Res Int. 2013;2013:410609.

    PubMed  PubMed Central  Google Scholar 

  45. 45.

    Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.

    CAS  PubMed  Article  Google Scholar 

  46. 46.

    Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.

    CAS  PubMed  Article  Google Scholar 

  47. 47.

    Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015.

  48. 48.

    Zhuo X, Zhang P, Barker L, et al. The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care. 2014;37(9):2557–64.

    PubMed  Article  Google Scholar 

  49. 49.

    Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–190. 215-357, iii-iv.

    CAS  Article  Google Scholar 

  50. 50.

    Keating CL, Dixon JB, Moodie ML, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009;32(4):567–74.

    PubMed  PubMed Central  Article  Google Scholar 

  51. 51.

    Hoerger TJ, Zhang P, Segel JE, et al. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010;33(9):1933–9.

    PubMed  PubMed Central  Article  Google Scholar 

  52. 52.

    Cremieux PY, Buchwald H, Shikora SA, et al. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008;14(9):589–96.

    PubMed  Google Scholar 

  53. 53.

    Warren JA, Ewing JA, Hale AL, et al. Cost-effectiveness of bariatric Surgery: increasing the economic viability of the most effective treatment for type II diabetes mellitus. Am Surg. 2015;81(8):807–11.

    PubMed  Google Scholar 

  54. 54.

    Li JF, Lai DD, Ni B, et al. Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Can J Surg. 2013;56(6):E158–64.

    PubMed  PubMed Central  Article  Google Scholar 

  55. 55.

    Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013;23(12):1994–2003.

    PubMed  Article  Google Scholar 

  56. 56.

    Zhang C, Yuan Y, Qiu C, et al. A meta-analysis of 2-year effect after surgery: laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity and diabetes mellitus. Obes Surg. 2014;24(9):1528–35.

    PubMed  Article  Google Scholar 

  57. 57.

    Yang X, Yang G, Wang W, et al. A meta-analysis: to compare the clinical results between gastric bypass and sleeve gastrectomy for the obese patients. Obes Surg. 2013;23(7):1001–10.

    PubMed  Article  Google Scholar 

  58. 58.

    Cho JM, Kim HJ, Menzo EL, et al. Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis. Surg Obes Relat Dis. 2015.

  59. 59.

    Wang MC, Guo XH, Zhang YW, et al. Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for obese patients with Type 2 diabetes: a meta-analysis of randomized controlled trials. Am Surg. 2015;81(2):166–71.

    PubMed  Google Scholar 

  60. 60.

    ASMBS Clinical Issues Committee. Bariatric surgery in class I obesity (body mass index 30–35 kg/m²). Surg Obes Relat Dis. 2013;9(1):e1–10.

  61. 61.

    Busetto L, Dixon J, De Luca M, et al. Bariatric surgery in class I obesity: a position statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2014;24(4):487–519.

    PubMed  Article  Google Scholar 

  62. 62.

    O’Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625–33.

    PubMed  Article  Google Scholar 

  63. 63.

    Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8.

    PubMed  Article  Google Scholar 

  64. 64.

    Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index <35 kg/m2. Diabetes Obes Metab. 2012;14(3):262–70.

  65. 65.

    Reis CE, Alvarez-Leite JI, Bressan J, et al. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14(4):365–72.

  66. 66.

    Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6(3):254–9.

    PubMed  Article  Google Scholar 

  67. 67.

    DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6(3):249–53.

    PubMed  Article  Google Scholar 

  68. 68.

    Hall TC, Pellen MG, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010;20(9):1245–50.

    PubMed  Article  Google Scholar 

  69. 69.

    Hamza N, Abbas MH, Darwish A, et al. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis. 2011;7(6):691–6.

    PubMed  Article  Google Scholar 

  70. 70.

    Hawa MI, Kolb H, Schloot N, et al. Action LADA consortium. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care. 2013;36(4):908–13.

    PubMed  PubMed Central  Article  Google Scholar 

  71. 71.

    Manning SB, Pucci A, Batterham RL, et al. Latent autoimmune diabetes in adults presenting as diabetes “recurrence” after bariatric surgery: a case report. Diabetes Care. 2013;36(8):e120.

    PubMed  PubMed Central  Article  Google Scholar 

  72. 72.

    Kashyap SR, Schauer P. Clinical considerations for the management of residual diabetes following bariatric surgery. Diabetes Obes Metab. 2012;14(9):773–79.

    CAS  PubMed  Article  Google Scholar 

  73. 73.

    Deitel M. Update: why diabetes does not resolve in some patients after bariatric surgery. Obes Surg. 2011;21(6):794–6.

    PubMed  Article  Google Scholar 

  74. 74.

    Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery. 2010;147(5):664–9.

    PubMed  Article  Google Scholar 

  75. 75.

    Czupryniak L, Wiszniewski M, Szymański D, et al. Long-term results of gastric bypass surgery in morbidly obese type 1 diabetes patients. Obes Surg. 2010;20(4):506–8.

    PubMed  Article  Google Scholar 

  76. 76.

    Mendez CE, Tanenberg RJ, Pories W. Outcomes of Roux-en-Y gastric bypass surgery for severely obese patients with type 1 diabetes: a case series report. Diabetes Metab Syndr Obes. 2010;3:281–3.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  77. 77.

    Reyes Garcia R, Romero Muñoz M, Galbis VH. Bariatric surgery in type 1 diabetes. Endocrinol Nutr. 2013;60(1):46–7.

    PubMed  Article  Google Scholar 

  78. 78.

    Breen DM, Rasmussen BA, Kokorovic A, et al. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med. 2012;18(6):950–5.

    CAS  PubMed  Article  Google Scholar 

  79. 79.

    Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993;44:121–31.

    CAS  PubMed  Article  Google Scholar 

  80. 80.

    Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62.

    PubMed  Article  Google Scholar 

  81. 81.

    Sattar N, McConnachie A, Shaper AG, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008;371(9628):1927–35.

    PubMed  Article  Google Scholar 

  82. 82.

    Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356–9.

    PubMed  Article  Google Scholar 

  83. 83.

    Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013;309(21):2250–61.

    CAS  PubMed  Article  Google Scholar 

  84. 84.

    Schauer PR, Bhatt DL, Kirwan JP, et al. STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.

    PubMed  Article  CAS  Google Scholar 

  85. 85.

    Kahn R. The metabolic syndrome (Emperor) wears no clothes. Diabetes Care. 2006;29(7):1693–6.

    Article  Google Scholar 

  86. 86.

    Prospective Studies Collaboration, Whitlock G, Lewington S, et al. Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.

    PubMed Central  Article  Google Scholar 

  87. 87.

    Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640–9.

    PubMed  Article  Google Scholar 

  88. 88.

    Batsis JA, Sarr MG, Collazo-Clavell ML, et al. Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol. 2008;102(7):930–7.

    PubMed  PubMed Central  Article  Google Scholar 

  89. 89.

    Vest AR, Heneghan HM, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98(24):1763–77.

    PubMed  Article  Google Scholar 

  90. 90.

    Busetto L, De Stefano F, Pigozzo S, et al. Long-term cardiovascular risk and coronary events in morbidly obese patients treated with laparoscopic gastric banding. Surg Obes Relat Dis. 2014;10(1):112–20.

    PubMed  Article  Google Scholar 

  91. 91.

    Kwok CS, Pradhan A, Khan MA, et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014;173(1):20–8.

    PubMed  Article  Google Scholar 

  92. 92.

    Johnson BL, Blackhurst DW, Latham BB, et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216(4):545–56.

    PubMed  Article  Google Scholar 

  93. 93.

    Sturm W, Tschoner A, Engl J, et al. Effect of bariatric surgery on both functional and structural measures of premature atherosclerosis. Eur Heart J. 2009;30(16):2038–43.

    PubMed  Article  Google Scholar 

  94. 94.

    Tschoner A, Sturm W, Gelsinger C, et al. Long-term effects of weight loss after bariatric surgery on functional and structural markers of atherosclerosis. Obesity (Silver Spring). 2013;21(10):1960–5.

    CAS  Article  Google Scholar 

  95. 95.

    Habib P, Scocco JD, Terek M, et al. Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol. 2009;104(9):1251–5.

    CAS  PubMed  Article  Google Scholar 

  96. 96.

    Saleh MH, Bertolami MC, Assef JE, et al. Improvement of atherosclerotic markers in non-diabetic patients after bariatric surgery. Obes Surg. 2012;22(11):1701–7.

    PubMed  Article  Google Scholar 

  97. 97.

    Sarmento PLFA, Plavnik FL, Zanella MT, et al. Association of carotid intima-media thickness and cardiovascular risk factors in women pre- and post-bariatric surgery. Obes Surg. 2009;19(3):339–44.

    CAS  PubMed  Article  Google Scholar 

  98. 98.

    Nerla R, Tarzia P, Sestito A, et al. Effect of bariatric surgery on peripheral flow mediated dilation and coronary microvascular function. Nutr Metab Cardiovasc Dis. 2012;22(8):626–34.

    CAS  PubMed  Article  Google Scholar 

  99. 99.

    Priester T, Ault TG, Davidson L, et al. Coronary calcium scores 6 years after bariatric surgery. Obes Surg. 2015;25(1):90–6.

  100. 100.

    Lopez-Jimenez F, Bhatia S, Collazo-Clavell ML, et al. Safety and efficacy of bariatric surgery in patients with coronary artery disease. Mayo Clin Proc. 2005;80(9):1157–62.

    PubMed  Article  Google Scholar 

  101. 101.

    Afolabi BA, Novaro GM, Szomstein S, et al. Cardiovascular complications of obesity surgery in patients with increased preoperative cardiac risk. Surg Obes Relat Dis. 2009;5(6):653–6.

    PubMed  Article  Google Scholar 

  102. 102.

    Delling L, Karason K, Olbers T, Sjöström D, Wahlstrand B, Carlsson B, et al. Feasibility of bariatric surgery as a strategy for secondary prevention in cardiovascular disease: a report from the Swedish Obese Subjects trial. J Obes. 2010;2010.

  103. 103.

    Ramani GV, McCloskey C, Ramanathan RC, et al. Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol. 2008;31(11):516–20.

    PubMed  Article  Google Scholar 

  104. 104.

    Miranda WR, Batsis JA, Sarr MG, et al. Impact of bariatric surgery on quality of life, functional capacity, and symptoms in patients with heart failure. Obes Surg. 2013;23(7):1011–5.

    PubMed  Article  Google Scholar 

  105. 105.

    Oreopoulos A, Padwal R, Kalantar-Zadeh K, et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156(1):13–22.

    PubMed  Article  Google Scholar 

  106. 106.

    Caceres M, Czer LS, Esmailian F, et al. Bariatric surgery in severe obesity and end-stage heart failure with mechanical circulatory support as a bridge to successful heart transplantation: a case report. Transplant Proc. 2013;45(2):798–9.

    CAS  PubMed  Article  Google Scholar 

  107. 107.

    Chaudhry UI, Kanji A, Sai-Sudhakar CB, et al. Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist device: medium-term results. Surg Obes Relat Dis. 2015;11(1):88–93.

    PubMed  Article  Google Scholar 

  108. 108.

    Wikiel KJ, McCloskey CA, Ramanathan RC. Bariatric surgery: a safe and effective conduit to cardiac transplantation. Surg Obes Relat Dis. 2014;10(3):479–84.

    PubMed  Article  Google Scholar 

  109. 109.

    Sarkhosh K, Switzer NJ, El-Hadi M, et al. The impact of bariatric surgery on obstructive sleep apnea: a systematic review. Obes Surg. 2013;23(3):414–23.

    PubMed  Article  Google Scholar 

  110. 110.

    Tishler PV, Larkin EK, Schluchter MD, et al. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA. 2003;289(17):2230–7.

    PubMed  Article  Google Scholar 

  111. 111.

    Pannain S, Mokhlesi B. Bariatric surgery and its impact on sleep architecture, sleep-disordered breathing, and metabolism. Best Pract Res Clin Endocrinol Metab. 2010;24(5):745–61.

    PubMed  Article  Google Scholar 

  112. 112.

    Drager LF, Togeiro SM, Polotsky VY, et al. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. 2013;62(7):569–76.

    PubMed  PubMed Central  Article  Google Scholar 

  113. 113.

    Dorkova Z, Petrasova D, Molcanyiova A, et al. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest. 2008;134(4):686–92.

    CAS  PubMed  Article  Google Scholar 

  114. 114.

    Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med. 2011;365(24):2277–86.

    CAS  PubMed  Article  Google Scholar 

  115. 115.

    Dixon JB, Schachter LM, O’Brien PE, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;308(11):1142–9.

    CAS  PubMed  Article  Google Scholar 

  116. 116.

    Gupta RM, Parvizi J, Hanssen AD, et al. Postoperative complications in patients with obstructive sleep apnea syndrome undergoing hip or knee replacement: a case-control study. Mayo Clin Proc. 2001;76(9):897–905.

    CAS  PubMed  Article  Google Scholar 

  117. 117.

    Hwang D, Shakir N, Limann B, et al. Association of sleep-disordered breathing with postoperative complications. Chest. 2008;133(5):1128–34.

    PubMed  Article  Google Scholar 

  118. 118.

    Ferreyra GP, Baussano I, Squadrone V, et al. Continuous positive airway pressure for treatment of respiratory complications after abdominal surgery: a systematic review and meta-analysis. Ann Surg. 2008;247(4):617–26.

    PubMed  Article  Google Scholar 

  119. 119.

    Khan A, King WC, Patterson EJ, et al. Assessment of obstructive sleep apnea in adults undergoing bariatric surgery in the longitudinal assessment of bariatric surgery-2 (LABS-2) study. J Clin Sleep Med. 2013;9(1):21–9.

    PubMed  PubMed Central  Google Scholar 

  120. 120.

    O’Keeffe T, Patterson EJ. Evidence supporting routine polysomnography before bariatric surgery. Obes Surg. 2004;14(1):23–6.

    PubMed  Article  Google Scholar 

  121. 121.

    Sharkey KM, Orff HJ, Tosi C, et al. Subjective sleepiness and daytime functioning in bariatric patients with obstructive sleep apnea. Sleep Breath. 2013;17(1):267–74.

    PubMed  Article  Google Scholar 

  122. 122.

    Gasa M, Salord N, Fortuna AM, et al. Optimizing screening of severe obstructive sleep apnea in patients undergoing bariatric surgery. Surg Obes Relat Dis. 2013;9(4):539–46.

    PubMed  Article  Google Scholar 

  123. 123.

    Dixon JB, Schachter LM, O’Brien PE. Predicting sleep apnea and excessive day sleepiness in the severely obese: indicators for polysomnography. Chest. 2003;123(4):1134–41.

    PubMed  Article  Google Scholar 

  124. 124.

    Sareli AE, Cantor CR, Williams NN, et al. Obstructive sleep apnea in patients undergoing bariatric surgery—a tertiary center experience. Obes Surg. 2011;21(3):316–27.

    PubMed  Article  Google Scholar 

  125. 125.

    Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007;175(7):661–6.

    PubMed  PubMed Central  Article  Google Scholar 

  126. 126.

    Juel CT, Ali Z, Nilas L, et al. Asthma and obesity: does weight loss improve asthma control? a systematic review. J Asthma Allergy. 2012;5:21–6.

    PubMed  PubMed Central  Google Scholar 

  127. 127.

    Macgregor AM, Greenberg RA. Effect of surgically induced weight loss on asthma in the morbidly obese. Obes Surg. 1993;3(1):15–21.

    PubMed  Article  Google Scholar 

  128. 128.

    Dixon JB, Chapman L, O’Brien P. Marked improvement in asthma after Lap-Band surgery for morbid obesity. Obes Surg. 1999;9(4):385–9.

    CAS  PubMed  Article  Google Scholar 

  129. 129.

    Dávila-Cervantes A, Domínguez-Cherit G, Borunda D, et al. Impact of surgically-induced weight loss on respiratory function: a prospective analysis. Obes Surg. 2004;14(10):1389–92.

    PubMed  Article  Google Scholar 

  130. 130.

    Spivak H, Hewitt MF, Onn A, et al. Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure. Am J Surg. 2005;189(1):27–32.

    PubMed  Article  Google Scholar 

  131. 131.

    Dhabuwala A, Cannan RJ, Stubbs RS. Improvement in co-morbidities following weight loss from gastric bypass surgery. Obes Surg. 2000;10(5):428–35.

    CAS  PubMed  Article  Google Scholar 

  132. 132.

    Dixon AE, Pratley RE, Forgione PM, et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol. 2011;128(3):508–15.

    PubMed  PubMed Central  Article  Google Scholar 

  133. 133.

    van Huisstede A, Rudolphus A, Castro Cabezas M, et al. Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma. Thorax. 2015;70(7):659–67.

    PubMed  Article  Google Scholar 

  134. 134.

    Dandona P, Ghanim H, Monte SV, et al. Increase in the mediators of asthma in obesity and obesity with type 2 diabetes: reduction with weight loss. Obesity (Silver Spring). 2014;22(2):356–62.

    CAS  Article  Google Scholar 

  135. 135.

    Blagojevic M, Jinks C, Jeffery A, et al. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2010;18(1):24–33.

    CAS  PubMed  Article  Google Scholar 

  136. 136.

    Grotle M, Hagen KB, Natvig B, et al. Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord. 2008;9:132.

  137. 137.

    Cooper C, Inskip H, Croft P, et al. Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol. 1998;147(6):516–22.

    CAS  PubMed  Article  Google Scholar 

  138. 138.

    Ackerman IN, Osborne RH. Obesity and increased burden of hip and knee joint disease in Australia: results from a national survey. BMC Musculoskelet Disord. 2012;13:254.

    PubMed  PubMed Central  Article  Google Scholar 

  139. 139.

    Christensen R, Bartels EM, Astrup A, et al. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2007;66(4):433–9.

    PubMed Central  Article  PubMed  Google Scholar 

  140. 140.

    Bordini B, Stea S, Cremonini S, et al. Relationship between obesity and early failure of total knee prostheses. BMC Musculoskelet Disord. 2009;10:29.

    PubMed  PubMed Central  Article  Google Scholar 

  141. 141.

    Kerkhoffs GM, Servien E, Dunn W, et al. The influence of obesity on the complication rate and outcome of total knee arthroplasty: a meta-analysis and systematic literature review. J Bone Joint Surg Am. 2012;94(20):1839–44.

    PubMed  PubMed Central  Article  Google Scholar 

  142. 142.

    Severson EP, Singh JA, Browne JA, et al. Total knee arthroplasty in morbidly obese patients treated with bariatric surgery: a comparative study. J Arthroplasty. 2012;27(9):1696–700.

    PubMed  PubMed Central  Article  Google Scholar 

  143. 143.

    Parvizi J, Trousdale RT, Sarr MG. Total joint arthroplasty in patients surgically treated for morbid obesity. J Arthroplasty. 2000;15(8):1003–8.

    CAS  PubMed  Article  Google Scholar 

  144. 144.

    Inacio MC, Paxton EW, Fisher D, et al. Bariatric surgery prior to total joint arthroplasty may not provide dramatic improvements in post-arthroplasty surgical outcomes. J Arthroplasty. 2014;29(7):1359–64.

    PubMed  PubMed Central  Article  Google Scholar 

  145. 145.

    Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101(11):2619–28.

    PubMed  Article  Google Scholar 

  146. 146.

    Eslick GD. Gastrointestinal symptoms and obesity: a meta-analysis. Obes Rev. 2012;13(5):469–79.

    CAS  PubMed  Article  Google Scholar 

  147. 147.

    El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53(9):2307–12.

    PubMed  PubMed Central  Article  Google Scholar 

  148. 148.

    Cai N, Ji GZ, Fan ZN, et al. Association between body mass index and erosive esophagitis: a meta-analysis. World J Gastroenterol. 2012;18(20):2545–53.

    PubMed  PubMed Central  Article  Google Scholar 

  149. 149.

    Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199–211.

    PubMed  Article  Google Scholar 

  150. 150.

    Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(5):872–8.

    PubMed  Article  Google Scholar 

  151. 151.

    Singh S, Sharma AN, Murad MH, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(11):1399–412. e7.

    PubMed  Article  Google Scholar 

  152. 152.

    Friedenberg FK, Xanthopoulos M, Foster GD, et al. The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol. 2008;103(8):2111–22.

    PubMed  Article  Google Scholar 

  153. 153.

    Ness-Jensen E, Lindam A, Lagergren J, et al. Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study. Am J Gastroenterol. 2013;108(3):376–82.

    PubMed  Article  Google Scholar 

  154. 154.

    Singh M, Lee J, Gupta N, et al. Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring). 2013;21(2):284–90.

    Article  Google Scholar 

  155. 155.

    Patterson EJ, Davis DG, Khajanchee Y, et al. Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn. Surg Endosc. 2003;17(10):1561–5.

    CAS  PubMed  Article  Google Scholar 

  156. 156.

    Varela JE, Hinojosa MW, Nguyen NT. Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease. Surg Obes Relat Dis. 2009;5(2):139–43.

    PubMed  Article  Google Scholar 

  157. 157.

    Prachand VN, Alverdy JC. Gastroesophageal reflux disease and severe obesity: fundoplication or bariatric surgery? World J Gastroenterol. 2010;16(30):3757–61.

    PubMed  PubMed Central  Article  Google Scholar 

  158. 158.

    Ikramuddin S. Surgical management of gastroesophageal reflux disease in obesity. Dig Dis Sci. 2008;53(9):2318–29.

    PubMed  Article  Google Scholar 

  159. 159.

    Pallati PK, Shaligram A, Shostrom VK, et al. Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: review of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2014;10(3):502–7.

    PubMed  Article  Google Scholar 

  160. 160.

    Nelson LG, Gonzalez R, Haines K, et al. Amelioration of gastroesophageal reflux symptoms following Roux-en-Y gastric bypass for clinically significant obesity. Am Surg. 2005;71(11):950–3.

    PubMed  Google Scholar 

  161. 161.

    Tai CM, Lee YC, Wu MS, et al. The effect of Roux-en-Y gastric bypass on gastroesophageal reflux disease in morbidly obese Chinese patients. Obes Surg. 2009;19(5):565–70.

    PubMed  Article  Google Scholar 

  162. 162.

    Madalosso CA, Gurski RR, Callegari-Jacques SM, et al. The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: a prospective study based on the Montreal Consensus. Ann Surg. 2010;251(2):244–8.

    PubMed  Article  Google Scholar 

  163. 163.

    Houghton SG, Romero Y, Sarr MG. Effect of Roux-en-Y gastric bypass in obese patients with Barrett’s esophagus: attempts to eliminate duodenogastric reflux. Surg Obes Relat Dis. 2008;4(1):1–4.

    PubMed  Article  Google Scholar 

  164. 164.

    Csendes A, Burgos AM, Smok G, et al. Effect of gastric bypass on Barrett’s esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg. 2006;10(2):259–64.

    PubMed  Article  Google Scholar 

  165. 165.

    Peterli R, Borbély Y, Kern B, et al. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg. 2013;258(5):690–4.

    PubMed  PubMed Central  Article  Google Scholar 

  166. 166.

    Stefanidis D, Navarro F, Augenstein VA, et al. Laparoscopic fundoplication takedown with conversion to Roux-en-Y gastric bypass leads to excellent reflux control and quality of life after fundoplication failure. Surg Endosc. 2012;26(12):3521–7.

    PubMed  Article  Google Scholar 

  167. 167.

    Kim M, Navarro F, Eruchalu CN, et al. Minimally invasive Roux-en-Y gastric bypass for fundoplication failure offers excellent gastroesophageal reflux control. Am Surg. 2014;80(7):696–703.

    PubMed  Google Scholar 

  168. 168.

    de Jong JR, Besselink MG, van Ramshorst B, et al. Effects of adjustable gastric banding on gastroesophageal reflux and esophageal motility: a systematic review. Obes Rev. 2010;11(4):297–305.

    PubMed  Article  Google Scholar 

  169. 169.

    Klaus A, Gruber I, Wetscher G, et al. Prevalent esophageal body motility disorders underlie aggravation of GERD symptoms in morbidly obese patients following adjustable gastric banding. Arch Surg. 2006;141(3):247–51.

    PubMed  Article  Google Scholar 

  170. 170.

    Gagner M, Deitel M, Erickson AL, et al. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg. 2013;23(12):2013–7.

    PubMed  Article  Google Scholar 

  171. 171.

    Laffin M, Chau J, Gill RS, et al. Sleeve gastrectomy and gastroesophageal reflux disease. J Obes. 2013;2013:741097.

    PubMed  PubMed Central  Article  Google Scholar 

  172. 172.

    Chiu S, Birch DW, Shi X, et al. Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis. 2011;7(4):510–5.

    PubMed  Article  Google Scholar 

  173. 173.

    Gulkarov I, Wetterau M, Ren CJ, et al. Hiatal hernia repair at the initial laparoscopic adjustable gastric band operation reduces the need for reoperation. Surg Endosc. 2008;22(4):1035–41.

    PubMed  Article  Google Scholar 

  174. 174.

    Parikh MS, Fielding GA, Ren CJ. U.S. experience with 749 laparoscopic adjustable gastric bands: intermediate outcomes. Surg Endosc. 2005;19(12):1631–5.

    CAS  PubMed  Article  Google Scholar 

  175. 175.

    Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–85.

    CAS  PubMed  Article  Google Scholar 

  176. 176.

    Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, et al. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010;1:CD007340.

    PubMed  Google Scholar 

  177. 177.

    Bower G, Toma T, Harling L, Jiao LR, Efthimiou E, Darzi A, et al. Bariatric Surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology. Obes Surg. 2015.

  178. 178.

    Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142(7):1592–609.

    PubMed  Article  Google Scholar 

  179. 179.

    Rabl C, Campos GM. The impact of bariatric surgery on nonalcoholic steatohepatitis. Semin Liver Dis. 2012;32(1):80–91.

    CAS  PubMed  Article  Google Scholar 

  180. 180.

    Nagem RG, Lázaro-da-Silva A, de Oliveira RM, et al. Gallstone-related complications after Roux-en-Y gastric bypass: a prospective study. Hepatobiliary Pancreat Dis Int. 2012;11(6):630–5.

    PubMed  Article  Google Scholar 

  181. 181.

    Scopinaro N, Gianetta E, Civalleri D, et al. Two years of clinical experience with biliopancreatic bypass for obesity. Am J Clin Nutr. 1980;33(2 Suppl):506–14.

    CAS  PubMed  Google Scholar 

  182. 182.

    Tsirline VB, Keilani ZM, El Djouzi S, et al. How frequently and when do patients undergo cholecystectomy after bariatric surgery? Surg Obes Relat Dis. 2014;10(2):313–21.

    PubMed  Article  Google Scholar 

  183. 183.

    Sakorafas GH, Milingos D, Peros G. Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy. Dig Dis Sci. 2007;52(5):1313–25.

  184. 184.

    Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88(10):1705–10.

    CAS  PubMed  Google Scholar 

  185. 185.

    Bardaro SJ, Gagner M, Consten E, et al. Routine cholecystectomy during laparoscopic biliopancreatic diversion with duodenal switch is not necessary. Surg Obes Relat Dis. 2007;3(5):549–53.

    PubMed  Article  Google Scholar 

  186. 186.

    Malik S, Mitchell JE, Engel S, et al. Psychopathology in bariatric surgery candidates: a review of studies using structured diagnostic interviews. Compr Psychiatry. 2014;55(2):248–59.

    PubMed  Article  Google Scholar 

  187. 187.

    Lin HY, Huang CK, Tai CM, et al. Psychiatric disorders of patients seeking obesity treatment. BMC Psychiatr. 2013;13:1.

    CAS  Article  Google Scholar 

  188. 188.

    Mühlhans B, Horbach T, de Zwaan M. Psychiatric disorders in bariatric surgery candidates: a review of the literature and results of a German prebariatric surgery sample. Gen Hosp Psychiatry. 2009;31(5):414–21.

    PubMed  Article  Google Scholar 

  189. 189.

    Kalarchian MA, Marcus MD, Levine MD, et al. Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry. 2007;164(2):328–34.

    PubMed  Article  Google Scholar 

  190. 190.

    Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis. 2013;9(2):159–91.

    PubMed  Article  Google Scholar 

  191. 191.

    Eldar S, Heneghan HM, Brethauer S, et al. A focus on surgical preoperative evaluation of the bariatric patient—the Cleveland Clinic protocol and review of the literature. Surgeon. 2011;9(5):273–7.

    CAS  PubMed  Article  Google Scholar 

  192. 192.

    Pickering RP, Grant BF, Chou SP, et al. Are overweight, obesity, and extreme obesity associated with psychopathology? Results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2007;68(7):998–1009.

    PubMed  Article  Google Scholar 

  193. 193.

    Mitchell JE, Selzer F, Kalarchian MA, et al. Psychopathology before surgery in the longitudinal assessment of bariatric surgery-3 (LABS-3) psychosocial study. Surg Obes Relat Dis. 2012;8(5):533–41.

    PubMed  PubMed Central  Article  Google Scholar 

  194. 194.

    Livhits M, Mercado C, Yermilov I, et al. Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg. 2012;22(1):70–89.

    PubMed  Article  Google Scholar 

  195. 195.

    de Zwaan M, Enderle J, Wagner S, et al. Anxiety and depression in bariatric surgery patients: a prospective, follow-up study using structured clinical interviews. J Affect Disord. 2011;133(1-2):61–8.

    PubMed  Article  Google Scholar 

  196. 196.

    Legenbauer T, De Zwaan M, Benecke A, et al. Depression and anxiety: their predictive function for weight loss in obese individuals. Obes Facts. 2009;2(4):227–34.

    PubMed  Article  Google Scholar 

  197. 197.

    Brunault P, Jacobi D, Miknius V, et al. High preoperative depression, phobic anxiety, and binge eating scores and low medium-term weight loss in sleeve gastrectomy obese patients: a preliminary cohort study. Psychosomatics. 2012;53(4):363–70.

    PubMed  Article  Google Scholar 

  198. 198.

    Edwards-Hampton SA, Madan A, Wedin S, et al. A closer look at the nature of anxiety in weight loss surgery candidates. Int J Psychiatry Med. 2014;47(2):105–13.

    PubMed  Article  Google Scholar 

  199. 199.

    Singh M. Mood, food, and obesity. Front Psychol. 2014;5:925.

    PubMed  PubMed Central  Article  Google Scholar 

  200. 200.

    Meye FJ, Adan RA. Feelings about food: the ventral tegmental area in food reward and emotional eating. Trends Pharmacol Sci. 2014;35(1):31–40.

    CAS  PubMed  Article  Google Scholar 

  201. 201.

    Akubuiro A, Bridget Zimmerman M, Boles Ponto LL, et al. Hyperactive hypothalamus, motivated and non-distractible chronic overeating in ADAR2 transgenic mice. Genes Brain Behav. 2013;12(3):311–22.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  202. 202.

    Hryhorczuk C, Sharma S, Fulton SE. Metabolic disturbances connecting obesity and depression. Front Neurosci. 2013;7:177.

    PubMed  PubMed Central  Article  Google Scholar 

  203. 203.

    Sharma S, Fulton S. Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry. Int J Obes (Lond). 2013;37(3):382–9.

    CAS  Article  Google Scholar 

  204. 204.

    Kok P, Roelfsema F, Frölich M, et al. Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women. Am J Physiol Endocrinol Metab. 2006;291(5):E1038–43.

    CAS  PubMed  Article  Google Scholar 

  205. 205.

    Ahmed AT, Warton EM, Schaefer CA, et al. The effect of bariatric surgery on psychiatric course among patients with bipolar disorder. Bipolar Disord. 2013;15(7):753–63.

    PubMed  PubMed Central  Article  Google Scholar 

  206. 206.

    Yska JP, van der Linde S, Tapper VV, et al. Influence of bariatric surgery on the use and pharmacokinetics of some major drug classes. Obes Surg. 2013;23(6):819–25.

    PubMed  Article  Google Scholar 

  207. 207.

    Cunningham JL, Merrell CC, Sarr M, et al. Investigation of antidepressant medication usage after bariatric surgery. Obes Surg. 2012;22(4):530–5.

    PubMed  Article  Google Scholar 

  208. 208.

    Smith A, Henriksen B, Cohen A. Pharmacokinetic considerations in Roux-en-Y gastric bypass patients. Am J Health Syst Pharm. 2011;68(23):2241–7.

    CAS  PubMed  Article  Google Scholar 

  209. 209.

    Brietzke E, Lafer B. Long-acting injectable risperidone in a bipolar patient submitted to bariatric surgery and intolerant to conventional mood stabilizers. Psychiatry Clin Neurosci. 2011;65(2):205.

    PubMed  Article  Google Scholar 

  210. 210.

    Tripp AC. Lithium toxicity after Roux-en-Y gastric bypass surgery. J Clin Psychopharmacol. 2011;31(2):261–2.

    PubMed  Article  Google Scholar 

  211. 211.

    Pramyothin P, Khaodhiar L. Metabolic syndrome with the atypical antipsychotics. Curr Opin Endocrinol Diabetes Obes. 2010;17(5):460–6.

    CAS  PubMed  Article  Google Scholar 

  212. 212.

    Deeks ED. Risperidone long-acting injection: in bipolar I disorder. Drugs. 2010;70(8):1001–12.

    CAS  PubMed  Article  Google Scholar 

  213. 213.

    Bobbioni-Harsch E, Guillermin ML, Habicht F. Reciprocal interactions between bariatric surgery and psychopathology. Rev Med Suisse. 2014;10(442):1721–6. French.

    PubMed  Google Scholar 

  214. 214.

    Svensson PA, Anveden Å, Romeo S, et al. Alcohol consumption and alcohol problems after bariatric surgery in the Swedish Obese Subjects study. Obesity (Silver Spring). 2013;21(12):2444–51.

    Article  Google Scholar 

  215. 215.

    Kudsi OY, Huskey K, Grove S, et al. Prevalence of preoperative alcohol abuse among patients seeking weight-loss surgery. Surg Endosc. 2013;27(4):1093–7.

    PubMed  Article  Google Scholar 

  216. 216.

    Heinberg LJ, Ashton K, Coughlin J. Alcohol and bariatric surgery: review and suggested recommendations for assessment and management. Surg Obes Relat Dis. 2012;8(3):357–63.

    PubMed  Article  Google Scholar 

  217. 217.

    Suzuki J, Haimovici F, Chang G. Alcohol use disorders after bariatric surgery. Obes Surg. 2012;22(2):201–7.

    PubMed  Article  Google Scholar 

  218. 218.

    Ertelt TW, Mitchell JE, Lancaster K, et al. Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set. Surg Obes Relat Dis. 2008;4(5):647–50.

    PubMed  Article  Google Scholar 

  219. 219.

    Saules KK, Wiedemann A, Ivezaj V, et al. Bariatric surgery history among substance abuse treatment patients: prevalence and associated features. Surg Obes Relat Dis. 2010;6(6):615–21.

    PubMed  Article  Google Scholar 

  220. 220.

    King WC, Chen JY, Mitchell JE, et al. Prevalence of alcohol use disorders before and after bariatric surgery. JAMA. 2012;307(23):2516–25.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  221. 221.

    Ostlund MP, Backman O, Marsk R, et al. Increased admission for alcohol dependence after gastric bypass surgery compared with restrictive bariatric surgery. JAMA Surg. 2013;148(4):374–7.

    PubMed  Article  Google Scholar 

  222. 222.

    Polston JE, Pritchett CE, Tomasko JM, et al. Roux-en-Y gastric bypass increases intravenous ethanol self-administration in dietary obese rats. PLoS One. 2013;8(12):e83741.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  223. 223.

    Maluenda F, Csendes A, De Aretxabala X, et al. Alcohol absorption modification after a laparoscopic sleeve gastrectomy due to obesity. Obes Surg. 2010;20(6):744–8.

    PubMed  Article  Google Scholar 

  224. 224.

    Thanos PK, Subrize M, Delis F, et al. Gastric bypass increases ethanol and water consumption in diet-induced obese rats. Obes Surg. 2012;22(12):1884–92.

    PubMed  PubMed Central  Article  Google Scholar 

  225. 225.

    McCormick LM, Buchanan JR, Onwuameze OE, et al. Beyond alcoholism: Wernicke-Korsakoff syndrome in patients with psychiatric disorders. Cogn Behav Neurol. 2011;24(4):209–16.

    PubMed  PubMed Central  Article  Google Scholar 

  226. 226.

    Ashton K, Heinberg L, Merrell J, et al. Pilot evaluation of a substance abuse prevention group intervention for at-risk bariatric surgery candidates. Surg Obes Relat Dis. 2013;9(3):462–7.

    PubMed  Article  Google Scholar 

  227. 227.

    Blum K, Bailey J, Gonzalez AM, Oscar-Berman M, Liu Y, Giordano J, et al. Neuro-genetics of reward deficiency syndrome (RDS) as the root cause of “addiction transfer”: a new phenomenon common after bariatric surgery. J Genet Syndr Gene Ther. 2011;2012(1).

  228. 228.

    Snyder AG. Psychological assessment of the patient undergoing bariatric surgery. Ochsner J. 2009;9(3):144–8.

    PubMed  PubMed Central  Google Scholar 

  229. 229.

    Friedman KE, Applegate KL, Grant J. Who is adherent with preoperative psychological treatment recommendations among weight loss surgery candidates? Surg Obes Relat Dis. 2007;3(3):376–82.

    PubMed  Article  Google Scholar 

  230. 230.

    Parker K, O’Brien P, Brennan L. Measurement of disordered eating following bariatric surgery: a systematic review of the literature. Obes Surg. 2014;24(6):945–53.

    PubMed  Article  Google Scholar 

  231. 231.

    Morrow J, Gluck M, Lorence M, et al. Night eating status and influence on body weight, body image, hunger, and cortisol pre- and post- Roux-en-Y Gastric Bypass (RYGB) surgery. Eat Weight Disord. 2008;13(4):e96–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  232. 232.

    Colles SL, Dixon JB. Night eating syndrome: impact on bariatric surgery. Obes Surg. 2006;16(7):811–20.

    PubMed  Article  Google Scholar 

  233. 233.

    Fierabracci P, Pinchera A, Martinelli S, et al. Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes. Obes Surg. 2011;21(1):54–60.

    PubMed  Article  Google Scholar 

  234. 234.

    Poirier P, Alpert MA, Fleisher LA, et al. Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation. 2009;120(1):86–95.

    PubMed  Article  Google Scholar 

  235. 235.

    Stocker DJ. Management of the bariatric surgery patient. Endocrinol Metab Clin North Am. 2003;32(2):437–57.

    PubMed  Article  Google Scholar 

  236. 236.

    DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356(21):2176–83.

    CAS  PubMed  Article  Google Scholar 

  237. 237.

    Ness-Abramof R, Nabriski D, Apovian CM, et al. Overnight dexamethasone suppression test: a reliable screen for Cushing’s syndrome in the obese. Obes Res. 2002;10(12):1217–21.

    CAS  PubMed  Article  Google Scholar 

  238. 238.

    Collazo-Clavell ML, Clark MM, McAlpine DE, et al. Assessment and preparation of patients for bariatric surgery. Mayo Clin Proc. 2006;81(10 Suppl):S11–7.

    PubMed  Article  Google Scholar 

  239. 239.

    Manco M, Nanni G, Tondolo V, et al. Hypocalcemia complicating near-total thyroidectomy in patients with coexisting lipid malabsorption due to biliopancreatic diversion. Obes Surg. 2004;14(10):1429–34.

    PubMed  Article  Google Scholar 

  240. 240.

    Pietras SM, Holick MF. Refractory hypocalcemia following near-total thyroidectomy in a patient with a prior Roux-en-Y gastric bypass. Obes Surg. 2009;19(4):524–6.

    PubMed  Article  Google Scholar 

  241. 241.

    Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab. 2006;91(11):4223–31.

    CAS  PubMed  Article  Google Scholar 

  242. 242.

    Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(11):4823–43.

    CAS  PubMed  Article  Google Scholar 

  243. 243.

    Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8(1):48–55.

    PubMed  Article  Google Scholar 

  244. 244.

    Rojas-Marcos PM, Rubio MA, Kreskshi WI, et al. Severe hypocalcemia following total thyroidectomy after biliopancreatic diversion. Obes Surg. 2005;15(3):431–4.

    PubMed  Article  Google Scholar 

  245. 245.

    Dalbeth N, Chen P, White M, et al. Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study. Ann Rheum Dis. 2014;73(5):797–802.

    CAS  PubMed  Article  Google Scholar 

  246. 246.

    Romero-Talamás H, Daigle CR, Aminian A, et al. The effect of bariatric surgery on gout: a comparative study. Surg Obes Relat Dis. 2014;10(6):1161–5.

    PubMed  Article  Google Scholar 

  247. 247.

    Bergendal A, Bremme K, Hedenmalm K, et al. Risk factors for venous thromboembolism in pre-and postmenopausal women. Thromb Res. 2012;130(4):596–601.

    CAS  PubMed  Article  Google Scholar 

  248. 248.

    Laliberté F, Dea K, Duh MS, et al. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy. Menopause. 2011;18(10):1052–9.

    PubMed  Article  Google Scholar 

  249. 249.

    Canonico M, Oger E, Conard J, et al. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. ESTHER Study J Thromb Haemost. 2006;4(6):1259–65.

    CAS  PubMed  Article  Google Scholar 

  250. 250.

    Pandey S, Pandey S, Maheshwari A, et al. The impact of female obesity on the outcome of fertility treatment. J Hum Reprod Sci. 2010;3(2):62–7.

    PubMed  PubMed Central  Article  Google Scholar 

  251. 251.

    Rich-Edwards JW, Goldman MB, Willett WC, et al. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol. 1994;171(1):171–7.

    CAS  PubMed  Article  Google Scholar 

  252. 252.

    van der Steeg JW, Steures P, Eijkemans MJ, et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008;23(2):324–8.

    PubMed  Article  Google Scholar 

  253. 253.

    Gil-Campos M, Cañete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr. 2004;23(5):963–74.

    CAS  PubMed  Article  Google Scholar 

  254. 254.

    Motta AB. The role of obesity in the development of polycystic ovary syndrome. Curr Pharm Des. 2012;18(17):2482–91.

    CAS  PubMed  Article  Google Scholar 

  255. 255.

    Baeten JM, Bukusi EA, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health. 2001;91(3):436–40.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  256. 256.

    Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004;103(2):219–24.

    PubMed  Article  Google Scholar 

  257. 257.

    Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord. 2001;25(8):1175–82.

    CAS  PubMed  Article  Google Scholar 

  258. 258.

    Weiss JL, Malone FD, Emig D, et al. Obesity, obstetric complications and cesarean delivery rate—a population-based screening study. Am J Obstet Gynecol. 2004;190(4):1091–7.

    PubMed  Article  Google Scholar 

  259. 259.

    Stothard KJ, Tennant PW, Bell R, et al. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA. 2009;301(6):636–50.

    CAS  PubMed  Article  Google Scholar 

  260. 260.

    Oken E, Taveras EM, Kleinman KP, et al. Gestational weight gain and child adiposity at age 3 years. Am J Obstet Gynecol. 2007;196(4):322.e1–8.

  261. 261.

    American College of Obstetricians and Gynecologists. ACOG committee opinion no. 549: obesity in pregnancy. Obstet Gynecol. 2013;121(1):213–7.

    Article  Google Scholar 

  262. 262.

    Sheiner E, Levy A, Silverberg D, et al. Pregnancy after bariatric surgery is not associated with adverse perinatal outcome. Am J Obstet Gynecol. 2004;190(5):1335–40.

    PubMed  Article  Google Scholar 

  263. 263.

    Martin LF, Finigan KM, Nolan TE. Pregnancy after adjustable gastric banding. Obstet Gynecol. 2000;95(6 Pt 1):927–30.

    CAS  PubMed  Google Scholar 

  264. 264.

    McTiernan A. Obesity and cancer: the risks, science, and potential management strategies. Oncology (Williston Park). 2005;19(7):871–81.

    Google Scholar 

  265. 265.

    Anderson AS, Caswell S. Obesity management—an opportunity for cancer prevention. Surgeon. 2009;7(5):282–5.

    CAS  PubMed  Article  Google Scholar 

  266. 266.

    Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol. 2002;3(9):565–74.

    PubMed  Article  Google Scholar 

  267. 267.

    Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38.

    PubMed  Article  Google Scholar 

  268. 268.

    Tee MC, Cao Y, Warnock GL, et al. Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis. Surg Endosc. 2013;27(12):4449–56.

    PubMed  PubMed Central  Article  Google Scholar 

  269. 269.

    Casagrande DS, Rosa DD, Umpierre D, et al. Incidence of cancer following bariatric surgery: systematic review and meta-analysis. Obes Surg. 2014;24(9):1499–509.

    PubMed  Article  Google Scholar 

  270. 270.

    Afshar S, Kelly SB, Seymour K, et al. The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis. Obes Surg. 2014;24(10):1793–9.

    PubMed  Article  Google Scholar 

  271. 271.

    Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335(7630):1134.

    PubMed  PubMed Central  Article  Google Scholar 

  272. 272.

    Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.

    PubMed  Article  Google Scholar 

  273. 273.

    Renehan AG, Soerjomataram I, Tyson M, et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer. 2010;126(3):692–702.

    CAS  PubMed  Article  Google Scholar 

  274. 274.

    Eliassen AH, Colditz GA, Rosner B, et al. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296(2):193–201.

    CAS  PubMed  Article  Google Scholar 

  275. 275.

    Lahmann PH, Lissner L, Gullberg B, et al. A prospective study of adiposity and postmenopausal breast cancer risk: the Malmö Diet and Cancer Study. Int J Cancer. 2003;103(2):246–52.

    CAS  PubMed  Article  Google Scholar 

  276. 276.

    Chang SH, Pollack LM, Colditz GA. Obesity, mortality, and life years lost associated with breast cancer in nonsmoking US Women, National Health Interview Survey, 1997–2000. Prev Chronic Dis. 2013;10:E186.

    PubMed  PubMed Central  Article  Google Scholar 

  277. 277.

    Minicozzi P, Berrino F, Sebastiani F, et al. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease. Eur J Cancer. 2013;49(18):3881–8.

    CAS  PubMed  Article  Google Scholar 

  278. 278.

    Petrelli JM, Calle EE, Rodriguez C, et al. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control. 2002;13(4):325–32.

    PubMed  Article  Google Scholar 

  279. 279.

    Howell A, Sims AH, Ong KR, et al. Mechanisms of disease: prediction and prevention of breast cancer—cellular and molecular interactions. Nat Clin Pract Oncol. 2005;2(12):635–46.

    CAS  PubMed  Article  Google Scholar 

  280. 280.

    Harvie M, Howell A, Vierkant RA, et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women’s health study. Cancer Epidemiol Biomarkers Prev. 2005;14(3):656–61.

    PubMed  Article  Google Scholar 

  281. 281.

    Havrilesky LJ, Maxwell GL, Myers ER. Cost-effectiveness analysis of annual screening strategies for endometrial cancer. Am J Obstet Gynecol. 2009;200(6):640.e1–8.

    Article  Google Scholar 

  282. 282.

    Kwon JS, Lu KH. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women. Obstet Gynecol. 2008;112(1):56–63.

    PubMed  Article  Google Scholar 

  283. 283.

    Rose PG. Endometrial carcinoma. N Engl J Med. 1996;335(9):640–9.

    CAS  PubMed  Article  Google Scholar 

  284. 284.

    von Gruenigen VE, Tian C, Frasure H, et al. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study. Cancer. 2006;107(12):2786–91.

    Article  Google Scholar 

  285. 285.

    Arem H, Park Y, Pelser C, et al. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst. 2013;105(5):342–9.

    PubMed  PubMed Central  Article  Google Scholar 

  286. 286.

    Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1531–43.

    CAS  PubMed  Google Scholar 

  287. 287.

    McCawley GM, Ferriss JS, Geffel D, et al. Cancer in obese women: potential protective impact of bariatric surgery. J Am Coll Surg. 2009;208(6):1093–8.

    PubMed  Article  Google Scholar 

  288. 288.

    Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17(4):796–802.

    Article  Google Scholar 

  289. 289.

    Ward KK, Roncancio AM, Shah NR, et al. Bariatric surgery decreases the risk of uterine malignancy. Gynecol Oncol. 2014;133(1):63–6.

    PubMed  Article  Google Scholar 

  290. 290.

    Gagné DJ, Papasavas PK, Maalouf M, et al. Obesity surgery and malignancy: our experience after 1500 cases. Surg Obes Relat Dis. 2009;5(2):160–4.

    PubMed  Article  Google Scholar 

  291. 291.

    Potluri K, Hou S. Obesity in kidney transplant recipients and candidates. Am J Kidney Dis. 2010;56(1):143–56.

    PubMed  Article  Google Scholar 

  292. 292.

    Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol. 2004;2(12):1048–58.

    PubMed  Article  Google Scholar 

  293. 293.

    Kemmer N, Neff GW, Franco E, et al. Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation. Transplantation. 2013;96(10):860–2.

    CAS  PubMed  Google Scholar 

  294. 294.

    Leonard J, Heimbach JK, Malinchoc M, et al. The impact of obesity on long-term outcomes in liver transplant recipients—results of the NIDDK liver transplant database. Am J Transplant. 2008;8(3):667–72.

    CAS  PubMed  Article  Google Scholar 

  295. 295.

    Conzen KD, Vachharajani N, Collins KM, et al. Morbid obesity in liver transplant recipients adversely affects long-term graft and patient survival in a single-institution analysis. HPB (Oxford). 2015;17(3):251–7.

    Article  Google Scholar 

  296. 296.

    Hakeem AR, Cockbain AJ, Raza SS, et al. Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl. 2013;19(5):551–62.

    PubMed  Article  Google Scholar 

  297. 297.

    Pieloch D, Dombrovskiy V, Osband AJ, et al. Morbid obesity is not an independent predictor of graft failure or patient mortality after kidney transplantation. J Ren Nutr. 2014;24(1):50–7.

    PubMed  Article  Google Scholar 

  298. 298.

    Curran SP, Famure O, Li Y, Kim SJ. Increased recipient body mass index is associated with acute rejection and other adverse outcomes after kidney transplantation. Transplantation. 2014;97(1):64–70.

    PubMed  Article  Google Scholar 

  299. 299.

    McCloskey CA, Ramani GV, Mathier MA, et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis. 2007;3(5):503–7.

    CAS  PubMed  Article  Google Scholar 

  300. 300.

    Newcombe V, Blanch A, Slater GH, et al. Laparoscopic adjustable gastric banding prior to renal transplantation. Obes Surg. 2005;15(4):567–70.

    PubMed  Article  Google Scholar 

  301. 301.

    Campsen J, Zimmerman M, Shoen J, et al. Adjustable gastric banding in a morbidly obese patient during liver transplantation. Obes Surg. 2008;18(12):1625–7.

    PubMed  Article  Google Scholar 

  302. 302.

    Porubsky M, Powelson JA, Selzer DJ, et al. Pancreas transplantation after bariatric surgery. Clin Transplant. 2012;26(1):E1–6.

    PubMed  Article  Google Scholar 

  303. 303.

    Al-Sabah S, Christou NV. Laparoscopic gastric bypass after cardiac transplantation. Surg Obes Relat Dis. 2008;4(5):668–70.

    PubMed  Article  Google Scholar 

  304. 304.

    Lin MY, Tavakol MM, Sarin A, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc. 2013;27(1):81–5.

    PubMed  Article  Google Scholar 

  305. 305.

    Al-Nowaylati AR, Al-Haddad BJ, Dorman RB, et al. Gastric bypass after liver transplantation. Liver Transpl. 2013;19(12):1324–9.

    PubMed  Article  Google Scholar 

  306. 306.

    Duchini A, Brunson ME. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity. Transplantation. 2001;72(1):156–9.

    CAS  PubMed  Article  Google Scholar 

  307. 307.

    Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008;4(2):159–64.

    PubMed  Article  Google Scholar 

  308. 308.

    Lin MY, Tavakol MM, Sarin A, et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis. 2013;9(5):653–8.

    PubMed  Article  Google Scholar 

  309. 309.

    Lazzati A, Iannelli A, Schneck AS, et al. Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery. Obes Surg. 2015;25(1):134–42.

    PubMed  Article  Google Scholar 

  310. 310.

    Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59(10):1492–5.

    PubMed  Article  Google Scholar 

  311. 311.

    Wakerley BR, Tan MH, Ting EY. Idiopathic intracranial hypertension. Cephalalgia. 2015;35(3):248–61.

    CAS  PubMed  Article  Google Scholar 

  312. 312.

    Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2012;83(5):488–94.

    PubMed  PubMed Central  Article  Google Scholar 

  313. 313.

    Curry Jr WT, Butler WE, Barker 2nd FG. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988–2002. Neurosurgery. 2005;57(1):97–108.

    PubMed  Article  Google Scholar 

  314. 314.

    Sugerman HJ, DeMaria EJ, Felton III WL, et al. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology. 1997;49(2):507–11.

    CAS  PubMed  Article  Google Scholar 

  315. 315.

    Menger RP, Connor Jr DE, Thakur JD, et al. A comparison of lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension: an analysis of economic impact and complications using the Nationwide Inpatient Sample. Neurosurg Focus. 2014;37(5):E4.

    PubMed  Article  Google Scholar 

  316. 316.

    Sugerman HJ, Felton 3rd WL, Sismanis A, et al. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg. 1999;229(5):634–40.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  317. 317.

    Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341:c2701.

    PubMed  PubMed Central  Article  Google Scholar 

  318. 318.

    Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med. 1974;133(5):802–7.

    CAS  PubMed  Article  Google Scholar 

  319. 319.

    Kupersmith MJ, Gamell L, Turbin R, et al. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998;50(4):1094–8.

    CAS  PubMed  Article  Google Scholar 

  320. 320.

    Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105(12):2313–7.

    CAS  PubMed  Article  Google Scholar 

  321. 321.

    Glueck CJ, Golnik KC, Aregawi D, et al. Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia. Transl Res. 2006;148(5):215–22.

    CAS  PubMed  Article  Google Scholar 

  322. 322.

    Sugerman HJ, Felton 3rd WL, Salvant Jr JB, et al. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology. 1995;45(9):1655–9.

    CAS  PubMed  Article  Google Scholar 

  323. 323.

    Chandra V, Dutta S, Albanese CT, et al. Clinical resolution of severely symptomatic pseudotumor cerebri after gastric bypass in an adolescent. Surg Obes Relat Dis. 2007;3(2):198–200.

    PubMed  Article  Google Scholar 

  324. 324.

    Nadkarni T, Rekate HL, Wallace D. Resolution of pseudotumor cerebri after bariatric surgery for related obesity. Case report J Neurosurg. 2004;101(5):878–80.

    PubMed  Google Scholar 

  325. 325.

    Levin AA, Hess D, Hohler AD. Treatment of idiopathic intracranial hypertension with gastric bypass surgery. Int J Neurosci. 2015;125(1):78–80.

    PubMed  Article  Google Scholar 

  326. 326.

    Fridley J, Foroozan R, Sherman V, et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg. 2011;114(1):34–9.

    PubMed  Article  Google Scholar 

  327. 327.

    Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7.

    CAS  PubMed  Article  Google Scholar 

  328. 328.

    Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  329. 329.

    Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752–61.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  330. 330.

    Netzer N, Gatterer H, Faulhaber M, et al. Hypoxia, oxidative stress and fat. Biomolecules. 2015;5(2):1143–50.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  331. 331.

    Schmidt FM, Weschenfelder J, Sander C, et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One. 2015;10(3):e0121971.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  332. 332.

    Nijhuis J, Rensen SS, Slaats Y, et al. Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring). 2009;17(11):2014–8.

    CAS  Article  Google Scholar 

  333. 333.

    Hu T, Li LF, Shen J, et al. Chronic inflammation and colorectal cancer: the role of vascular endothelial growth factor. Curr Pharm Des. 2015;21(21):2960–7.

    CAS  PubMed  Article  Google Scholar 

  334. 334.

    Tilg H, Moschen AR. Mechanisms behind the link between obesity and gastrointestinal cancers. Best Pract Res Clin Gastroenterol. 2014;28(4):599–610.

    CAS  PubMed  Article  Google Scholar 

  335. 335.

    Long E, Beales IL. The role of obesity in oesophageal cancer development. Therap Adv Gastroenterol. 2014;7(6):247–68.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  336. 336.

    Cottam D, Fisher B, Ziemba A, et al. Tumor growth factor expression in obesity and changes in expression with weight loss: another cause of increased virulence and incidence of cancer in obesity. Surg Obes Relat Dis. 2010;6(5):538–41.

    PubMed  Article  Google Scholar 

  337. 337.

    Cottam DR, Schaefer PA, Shaftan GW, et al. Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes Surg. 2002;12(3):335–42.

    CAS  PubMed  Article  Google Scholar 

  338. 338.

    van Dielen FM, Buurman WA, Hadfoune M, et al. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab. 2004;89(8):4062–8.

    PubMed  Article  CAS  Google Scholar 

  339. 339.

    Hanusch-Enserer U, Cauza E, Spak M, et al. Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord. 2003;27(3):355–61.

    CAS  PubMed  Article  Google Scholar 

  340. 340.

    Santos J, Salgado P, Santos C, et al. Effect of bariatric surgery on weight loss, inflammation, iron metabolism, and lipid profile. Scand J Surg. 2014;103(1):21–5.

    CAS  PubMed  Article  Google Scholar 

  341. 341.

    Carlsson LM, Romeo S, Jacobson P, et al. The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial. Int J Obes (Lond). 2015;39(1):169–75.

    CAS  Article  Google Scholar 

  342. 342.

    Miras AD, le Roux CW. Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health. Lancet Diabetes Endocrinol. 2014;2(2):141–51.

    PubMed  Article  Google Scholar 

  343. 343.

    Navaneethan SD, Yehnert H, Moustarah F, et al. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4(10):1565–74.

    PubMed  PubMed Central  Article  Google Scholar 

  344. 344.

    Iaconelli A, Panunzi S, De Gaetano A, et al. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care. 2011;34(3):561–7.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  345. 345.

    Miras AD, Chuah LL, Lascaratos G, et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care. 2012;35(12):e81.

    PubMed  PubMed Central  Article  Google Scholar 

  346. 346.

    Fenske WK, Dubb S, Bueter M, et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis. 2013;9(4):559–68.

    PubMed  Article  Google Scholar 

  347. 347.

    Heneghan HM, Cetin D, Navaneethan SD, et al. Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 2013;9(1):7–14.

  348. 348.

    Navaneethan SD, Malin SK, Arrigain S, et al. Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study. Am J Kidney Dis. 2015;65(2):345–7.

    PubMed  Article  Google Scholar 

  349. 349.

    Jamal MH, Corcelles R, Daigle CR, et al. Safety and effectiveness of bariatric surgery in dialysis patients and kidney transplantation candidates. Surg Obes Relat Dis. 2015;11(2):419–23.

    PubMed  Article  Google Scholar 

  350. 350.

    Modanlou KA, Muthyala U, Xiao H, et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation. 2009;87(8):1167–73.

    PubMed  PubMed Central  Article  Google Scholar 

  351. 351.

    Lafranca JA, JN IJ, Betjes MG, Dor FJ. Body mass index and outcome in renal transplant recipients: a systematic review and meta-analysis. BMC Med. 2015;13(1):111. Erratum in BMC Med. 2015;13:141.

  352. 352.

    Subak LL, King WC, Belle SH, et al. Urinary incontinence before and after bariatric surgery. JAMA Intern Med. 2015;175(8):1378–87.

    PubMed  PubMed Central  Article  Google Scholar 

  353. 353.

    Steele T, Cuthbertson DJ, Wilding JPH. Impact of bariatric surgery on physical functioning in obese adults. Obes Rev. 2015;16(3):248–58.

    CAS  PubMed  Article  Google Scholar 

  354. 354.

    Maniscalco M, Zedda A, Giardiello C, et al. Effect of bariatric surgery on the six-minute walk test in severe uncomplicated obesity. Obes Surg. 2006;16(7):836–41.

    PubMed  Article  Google Scholar 

  355. 355.

    Tompkins J, Bosch PR, Chenowith R, et al. Changes in functional walking distance and health-related quality of life after gastric bypass surgery. Phys Ther. 2008;88(8):928–35.

    PubMed  Article  Google Scholar 

  356. 356.

    de Souza SA, Faintuch J, Fabris SM, et al. Six-minute walk test: functional capacity of severely obese before and after bariatric surgery. Surg Obes Relat Dis. 2009;5(5):540–3.

    PubMed  Article  Google Scholar 

  357. 357.

    Josbeno DA, Jakicic JM, Hergenroeder A, et al. Physical activity and physical function changes in obese individuals after gastric bypass surgery. Surg Obes Relat Dis. 2010;6(4):361–6.

    PubMed  Article  Google Scholar 

  358. 358.

    De Souza SA, Faintuch J, Sant’anna AF. Effect of weight loss on aerobic capacity in patients with severe obesity before and after bariatric surgery. Obes Surg. 2010;20(7):871–5.

    PubMed  Article  Google Scholar 

  359. 359.

    Lyytinen T, Liikavainio T, Pääkkönen M, et al. Physical function and properties of quadriceps femoris muscle after bariatric surgery and subsequent weight loss. J Musculoskelet Neuronal Interact. 2013;13(3):329–38.

    CAS  PubMed  Google Scholar 

  360. 360.

    Vargas CB, Picolli F, Dani C, et al. Functioning of obese individuals in pre- and postoperative periods of bariatric surgery. Obes Surg. 2013;23(10):1590–5.

    CAS  PubMed  Article  Google Scholar 

  361. 361.

    Iossi MF, Konstantakos EK, Teel 2nd DD, et al. Musculoskeletal function following bariatric surgery. Obesity (Silver Spring). 2013;21(6):1104–10.

    Article  Google Scholar 

  362. 362.

    Miller GD, Nicklas BJ, You T, et al. Physical function improvements after laparoscopic Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2009;5(5):530–7.

    PubMed  Article  Google Scholar 

  363. 363.

    Kanoupakis E, Michaloudis D, Fraidakis O, et al. Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity. Obes Surg. 2001;11(5):552–8.

    CAS  PubMed  Article  Google Scholar 

  364. 364.

    Serés L, Lopez-Ayerbe J, Coll R, et al. Increased exercise capacity after surgically induced weight loss in morbid obesity. Obesity (Silver Spring). 2006;14(2):273–9.

    Article  Google Scholar 

  365. 365.

    Valezi AC, Machado VH. Morphofunctional evaluation of the heart of obese patients before and after bariatric surgery. Obes Surg. 2011;21(11):1693–7.

    PubMed  Article  Google Scholar 

  366. 366.

    Wasmund SL, Owan T, Yanowitz FG, et al. Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study. Heart Rhythm. 2011;8(1):84–90.

    PubMed  Article  Google Scholar 

  367. 367.

    Wilms B, Ernst B, Thurnheer M, et al. Differential changes in exercise performance after massive weight loss induced by bariatric surgery. Obes Surg. 2013;23(3):365–71.

    PubMed  Article  Google Scholar 

  368. 368.

    Castello V, Simões RP, Bassi D, et al. Impact of aerobic exercise training on heart rate variability and functional capacity in obese women after gastric bypass surgery. Obes Surg. 2011;21(11):1739–49.

    PubMed  Article  Google Scholar 

  369. 369.

    Stegen S, Derave W, Calders P, et al. Physical fitness in morbidly obese patients: effect of gastric bypass surgery and exercise training. Obes Surg. 2011;21(1):61–70.

    PubMed  Article  Google Scholar 

  370. 370.

    Terranova L, Busetto L, Vestri A, et al. Bariatric surgery: cost-effectiveness and budget impact. Obes Surg. 2012;22(4):646–53.

    PubMed  Article  Google Scholar 

  371. 371.

    Hernæs UJ, Andersen JR, Norheim OF, et al. Work participation among the morbidly obese seeking bariatric surgery: an exploratory study from Norway. Obes Surg. 2015;25(2):271–8.

    PubMed  Article  Google Scholar 

  372. 372.

    Sjöström L, Larsson B, Backman L, et al. Swedish Obese Subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord. 1992;16(6):465–79.

    PubMed  Google Scholar 

  373. 373.

    Narbro K, Agren G, Jonsson E, et al. Sick leave and disability pension before and after treatment for obesity: a report from the Swedish Obese Subjects (SOS) study. Int J Obes Relat Metab Disord. 1999;23(6):619–24.

    CAS  PubMed  Article  Google Scholar 

  374. 374.

    Gripeteg L, Lindroos AK, Peltonen M, et al. Effects of bariatric surgery on disability pension in Swedish obese subjects. Int J Obes (Lond). 2012;36(3):356–62.

    CAS  Article  Google Scholar 

  375. 375.

    Kolotkin RL, Meter K, Williams GR. Quality of life and obesity. Obes Rev. 2001;2(4):219–29.

    CAS  PubMed  Article  Google Scholar 

  376. 376.

    Larsson U, Karlsson J, Sullivan M. Impact of overweight and obesity on health-related quality of life—a Swedish population study. Int J Obes Relat Metab Disord. 2002;26(3):417–24.

    CAS  PubMed  Article  Google Scholar 

  377. 377.

    Doll HA, Petersen SE, Stewart-Brown SL. Obesity and physical and emotional well-being: associations between body mass index, chronic illness, and the physical and mental components of the SF-36 questionnaire. Obes Res. 2000;8(2):160–70.

    CAS  PubMed  Article  Google Scholar 

  378. 378.

    Kolotkin RL, Crosby RD, Williams GR, et al. The relationship between health-related quality of life and weight loss. Obes Res. 2001;9(9):564–71.

    CAS  PubMed  Article  Google Scholar 

  379. 379.

    Karlsson J, Taft C, Sjöström L, et al. Psychosocial functioning in the obese before and after weight reduction: construct validity and responsiveness of the Obesity-related Problems scale. Int J Obes Relat Metab Disord. 2003;27(5):617–30.

    CAS  PubMed  Article  Google Scholar 

  380. 380.

    Karlsson J, Taft C, Rydén A, et al. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond). 2007;31(8):1248–61.

    CAS  Article  Google Scholar 

  381. 381.

    Magallares A, Schomerus G. Mental and physical health-related quality of life in obese patients before and after bariatric surgery: a meta-analysis. Psychol Health Med. 2015;20(2):165–76.

    PubMed  Article  Google Scholar 

  382. 382.

    Batsis JA, Lopez-Jimenez F, Collazo-Clavell ML, et al. Quality of life after bariatric surgery: a population-based cohort study. Am J Med. 2009;122(11):1055.e1–1055.e10.

    Article  Google Scholar 

  383. 383.

    Suter M, Donadini A, Romy S, et al. Laparoscopic Roux-en-Y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg. 2011;254(2):267–73.

    PubMed  Article  Google Scholar 

  384. 384.

    Burgmer R, Legenbauer T, Müller A, et al. Psychological outcome 4 years after restrictive bariatric surgery. Obes Surg. 2014;24(10):1670–8.

  385. 385.

    Black JA, White B, Viner RM, et al. Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis. Obes Rev. 2013;14(8):634–44.

    CAS  PubMed  Article  Google Scholar 

  386. 386.

    Kakoulidis TP, Karringer A, Gloaguen T, et al. Initial results with sleeve gastrectomy for patients with class I obesity (BMI 30-35 kg/m2). Surg Obes Relat Dis. 2009;5(4):425–8.

    PubMed  Article  Google Scholar 

  387. 387.

    O’Brien PE, Sawyer SM, Laurie C, et al. Laparoscopic adjustable gastric banding in severely obese adolescents; a randomized trial. JAMA. 2010;303(6):519–26.

    PubMed  Article  Google Scholar 

  388. 388.

    Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641.

    PubMed  Google Scholar 

  389. 389.

    Faulconbridge LF, Wadden TA, Thomas JG, et al. Changes in depression and quality of life in obese individuals with binge eating disorder: bariatric surgery versus lifestyle modification. Surg Obes Relat Dis. 2013;9:790–6.

    PubMed  Article  Google Scholar 

  390. 390.

    Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.

    PubMed  PubMed Central  Article  Google Scholar 

  391. 391.

    Kolotkin RL, Davidson LE, Crosby RD, et al. Six-year changes in health-related quality of life in gastric bypass patients versus obese comparison groups. Surg Obes Relat Dis. 2012;8(5):625–33.

    PubMed  PubMed Central  Article  Google Scholar 

  392. 392.

    Nguyen NT, Slone JA, Nguyen XM, et al. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg. 2009;250(4):631–41.

    PubMed  Google Scholar 

  393. 393.

    Søvik TT, Aasheim ET, Taha O, et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. Ann Intern Med. 2011;155(5):281–91.

    PubMed  Article  Google Scholar 

  394. 394.

    Strain GW, Kolotkin RL, Dakin GF, et al. The effects of weight loss after bariatric surgery on health-related quality of life and depression. Nutr Diabetes. 2014;4:e132.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  395. 395.

    Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics. 2004;114(1):217–23.

    PubMed  Article  Google Scholar 

  396. 396.

    Freedman DS, Mei Z, Srinivasan SR, et al. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr. 2007;150(1):12–7. e2.

    PubMed  Article  Google Scholar 

  397. 397.

    Pratt JS, Lenders CM, Dionne EA, et al. Best practice updates for pediatric/adolescent weight loss surgery. Obesity (Silver Spring). 2009;17(5):901–10.

    Article  Google Scholar 

  398. 398.

    Fried M, Hainer V, Basdevant A, et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (Lond). 2007;31(4):569–77.

    CAS  Google Scholar 

  399. 399.

    Treadwell JR, Sun F, Schoelles K. Systematic review and meta-analysis of bariatric surgery for pediatric obesity. Ann Surg. 2008;248(5):763–76.

    PubMed  Article  Google Scholar 

  400. 400.

    Michalsky M, Reichard K, Inge T, et al. American Society for Metabolic and Bariatric Surgery. ASMBS pediatric committee best practice guidelines. Surg Obes Relat Dis. 2012;8(1):1–7.

    PubMed  Article  Google Scholar 

  401. 401.

    Società Italiana di Chirurgia dell’Obesità e delle malattie metaboliche (S.I.C.OB.). Linee guida e stato dell’arte della chirurgia bariatrica e metabolica in Italia. Napoli: EdiSES; 2008.

  402. 402.

    Sugerman HJ, DeMaria EJ, Kellum JM, et al. Effects of bariatric surgery in older patients. Ann Surg. 2004;240(2):243–7.

    PubMed  PubMed Central  Article  Google Scholar 

  403. 403.

    Quebbemann B, Engstrom D, Siegfried T, et al. Bariatric surgery in patients older than 65 years is safe and effective. Surg Obes Relat Dis. 2005;1(4):389–92.

  404. 404.

    Hazzan D, Chin EH, Steinhagen E, et al. Laparoscopic bariatric surgery can be safe for treatment of morbid obesity in patients older than 60 years. Surg Obes Relat Dis. 2006;2(6):613–6.

  405. 405.

    Taylor CJ, Layani L. Laparoscopic adjustable gastric banding in patients > or =60 years old: is it worthwhile? Obes Surg. 2006;16(12):1579–83.

  406. 406.

    Dunkle-Blatter SE, St Jean MR, Whitehead C, et al. Outcomes among elderly bariatric patients at a high-volume center. Surg Obes Relat Dis. 2007;3(2):163–9.

    PubMed  Article  Google Scholar 

  407. 407.

    Busetto L, Angrisani L, Basso N, et al. Safety and efficacy of laparoscopic adjustable gastric banding in the elderly. Obesity (Silver Spring). 2008;16(2):334–8.

    Article  Google Scholar 

  408. 408.

    Villareal DT, Apovian CM, Kushner RF, et al. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, the Obesity Society. Am J Clin Nutr. 2005;82(5):923–34.

    CAS  PubMed  Google Scholar 

  409. 409.

    InterAct Consortium, Langenberg C, Sharp SJ, et al. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med. 2012;9(6):e1001230.

    Article  Google Scholar 

  410. 410.

    Thomas EL, Parkinson JR, Frost GS, et al. The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring). 2012;20(1):76–87.

    CAS  Article  Google Scholar 

  411. 411.

    Klöting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab. 2010;299(3):E506–15.

    PubMed  Article  CAS  Google Scholar 

  412. 412.

    Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168(15):1609–16.

    PubMed  Article  Google Scholar 

  413. 413.

    Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350(25):2549–57.

    CAS  PubMed  Article  Google Scholar 

  414. 414.

    Thorne A, Lonnqvist F, Apelman J, et al. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord. 2002;26(2):193–9.

    CAS  PubMed  Article  Google Scholar 

  415. 415.

    Fabbrini E, Tamboli RA, Magkos F, et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology. 2010;139(2):448–55.

    PubMed  PubMed Central  Article  Google Scholar 

  416. 416.

    Vilarrasa N, de Gordejuela AG, Gómez-Vaquero C, et al. Effect of bariatric surgery on bone mineral density: comparison of gastric bypass and sleeve gastrectomy. Obes Surg. 2013;23(12):2086–91.

    PubMed  Article  Google Scholar 

  417. 417.

    Wucher H, Ciangura C, Poitou C, et al. Effects of weight loss on bone status after bariatric surgery: association between adipokines and bone markers. Obes Surg. 2008;18(1):58–65.

    PubMed  Article  Google Scholar 

  418. 418.

    Nakamura KM, Haglind EG, Clowes JA, et al. Fracture risk following bariatric surgery: a population-based study. Osteoporos Int. 2014;25(1):151–8.

    CAS  PubMed  Article  Google Scholar 

  419. 419.

    Lalmohamed A, de Vries F, Bazelier MT, et al. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ. 2012;345:e5085.

    PubMed  PubMed Central  Article  Google Scholar 

  420. 420.

    Berarducci A, Haines K, Murr MM. Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesity. Appl Nurs Res. 2009;22(1):35–41.

    PubMed  Article  Google Scholar 

  421. 421.

    Ahlin S, Peltonen M, Anveden Ĺ, Jacobson P, Sjöholm K, Svensson PA, et al. Bariatric surgery increases the risk of osteoporosis and fractures in women in the Swedish Obese subjects study. Obes Facts 2015;8(suppl 1): T8:OS3.3

  422. 422.

    Yu EW, Bouxsein ML, Roy AE, et al. Bone loss after bariatric surgery: discordant results between DXA and QCT bone density. J Bone Miner Res. 2014;29(3):542–50.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  423. 423.

    Bosy-Westphal A, Müller MJ. Identification of skeletal muscle mass depletion across age and BMI groups in health and disease—there is need for a unified definition. Int J Obes (Lond). 2015;39(3):379–86.

    CAS  Article  Google Scholar 

  424. 424.

    Tamboli RA, Hossain HA, Marks PA, et al. Body composition and energy metabolism following Roux-en-Y gastric bypass surgery. Obesity (Silver Spring). 2010;18(9):1718–24.

    CAS  Article  Google Scholar 

  425. 425.

    Carey DG, Pliego GJ, Raymond RL. Body composition and metabolic changes following bariatric surgery: effects on fat mass, lean mass and basal metabolic rate: six months to one-year follow-up. Obes Surg. 2006;16(12):1602–8.

    PubMed  Article  Google Scholar 

  426. 426.

    Pouwels S, Wit M, Teijink JA, et al. Aspects of exercise before or after bariatric surgery: a systematic review. Obes Facts. 2015;8(2):132–46.

    PubMed  Article  Google Scholar 

  427. 427.

    Herman KM, Carver TE, Christou NV, et al. Physical activity and sitting time in bariatric surgery patients 1–16 years post-surgery. Clin Obes. 2014;4(5):267–76.

  428. 428.

    Chaston TB, Dixon JB, O’Brien PE. Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes (Lond). 2007;31(5):743–50.

    CAS  Google Scholar 

  429. 429.

    Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 Kg/m2: an integrative review of early studies. Obes Surg. 2010;20(6):776–90.

  430. 430.

    Scopinaro N, Adami GF, Papadia FS, et al. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30–35 kg/m2) and simple overweight (BMI 25–30 kg/m2): a prospective controlled study. Obes Surg. 2011;21(7):880–8.

  431. 431.

    2004 ASBS Consensus Conference on Surgery for Severe Obesity. Surg Obes Relat Dis. 2005;1(3):297–381.

  432. 432.

    Sauerland S, Angrisani L, Belachew M, et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2005;19(2):200–21.

    CAS  PubMed  Article  Google Scholar 

  433. 433.

    Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251(3):399–405.

    PubMed  Article  Google Scholar 

  434. 434.

    Maglione MA, Gibbons MM, Livhits M, Ewing B, Hu J, Ruelaz Maher A, et al. Bariatric surgery and nonsurgical therapy in adults with metabolic conditions and a body mass index of 30.0 to 34.9 kg/m2. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013. Report No.: 12(13)-EHC139-EF.

  435. 435.

    Parikh M, Issa R, Vieira D, et al. Role of bariatric surgery as treatment for type 2 diabetes in patients who do not meet current NIH criteria: a systematic review and meta-analysis. J Am Coll Surg. 2013;217(3):527–32.

    PubMed  Article  Google Scholar 

  436. 436.

    Demaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the bariatric outcomes longitudinal database. Ann Surg. 2010;252(3):559–66.

    PubMed  Google Scholar 

  437. 437.

    Angrisani L, Favretti F, Furbetta F, et al. Italian Group for Lap-Band System: results of multicenter study on patients with BMI < or =35 kg/m2. Obes Surg. 2004;14(3):415–8.

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Maurizio De Luca.

Ethics declarations

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

De Luca, M., Angrisani, L., Himpens, J. et al. Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). OBES SURG 26, 1659–1696 (2016). https://doi.org/10.1007/s11695-016-2271-4

Download citation

  • Published:

  • Issue Date: